|
|
|
 Memory Tests
Provista Memory Test
Plus™
The Provista Memory Test Plus™: The only FDA-cleared "Smell Test"available
 The loss of the sense of smell may indicate a medical problem
that requires follow-up by a physician. Early detection of developing medical
conditions can lead to early treatment and improved quality of life.
The Provista Memory Test Plus
- The only FDA-cleared "smell test" on the
market
- Self administered and self scored
- Simple and easy to use; painless and
non-invasive
- Consists of 12 odor strips to identify and
record
- Results in 5 minutes
The Provista Memory Test Plus is based on
extensive research from major universities, sponsored in part by the National
Institutes on Health and Aging. It
is the most widely employed means of assessing the sense of smell – it’s an eye
chart for your nose.
|
|
Medical and Scientific References
|
-
“Impaired
olfaction as a marker for cognitive decline” Neurology,
Graves, et.al., October 1999 Volume 53 Number 73
-
“Olfaction in Neurodegenerative Disease” Archives of Neurology, Mesholam,
et.al., January 1998 Volume 51
-
“Olfactory
Deficits in Patients with Mild Cognitive Impairment Predict Alzheimer’s Disease
at Follow up” American Journal of Psychiatry, Devanand, et.al.,
157:9, September 2000
-
“Olfactory
Dysfunction Discriminates Probable Alzheimer’s Dementia from Major Depression”
Journal Neuropsychiatry & Clinical Neuroscience, Solomon, et.al., 12:1, Winter
2000
-
“Olfactory
Identification and Incidence of Mild Cognitive Impairment in Older Age”
Arch Gen Psychiatry, Wilson Ph.D. et.al., Vol. 64 (No. 7) July 2007
-
“Olfactory
Dysfunction As a Predictor of Neurodegenerative Disease” Current
Neurology and Neuroscience Reports, Albers et.al., Vol. 6; 379-386, 2006
-
“Olfactory
Screening Test in Mild Cognitive Impairment” Neurol Sci, Eibenstein
et.al., Vol. 26: 156-160 2005
-
“Olfactory
Function in Mild Cognitive Impairment and Alzheimer’s Disease” Am J
Psychiatry, Peters, M.D. et.al., Vol. 160:11, November 2003
|
|